QSHC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foy, R
Right arrow Articles by Warner, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foy, R
Right arrow Articles by Warner, P
Qual Saf Health Care 2003;12:205-209
© 2003 BMJ Publishing Group & Institute for Healthcare Improvement


CLINICAL GUIDELINE

About time: diagnostic guidelines that help clinicians

R Foy1, P Warner2

1 Department of Reproductive and Developmental Sciences, University of Edinburgh, Edinburgh EH3 9ER, UK
2 Public Health Sciences, Department of Community Health Sciences, University of Edinburgh, Edinburgh EH8 9AG, UK

Correspondence to:
R Foy, Centre for Health Services Research, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4AA, UK;
R.C.Foy{at}ncl.ac.uk
ABSTRACT
Clinical guidelines often make recommendations on the use of diagnostic tests. Compared with sensitivity and specificity, the use of pre- and post-test probabilities allows a more explicit and rational selection and interpretation of diagnostic tests. Ideally, clinical guidelines relating to diagnosis should routinely incorporate this information to enhance individualised decision making. We report our experience of incorporating pre- and post-test probabilities into a guideline on the investigation of women with postmenopausal bleeding developed by the Scottish Intercollegiate Guidelines Network. Issues relating to their application are highlighted, including the limitations of available evidence on diagnostic tests and prevalence of disease, acceptability to guideline users, and the uncertain impact on actual clinical decision making. Despite these potential difficulties, the incorporation of data on pre- and post-test probabilities into the development and presentation of guideline recommendations may offer an important opportunity to make clinical decision making more transparent for both clinicians and patients.


Keywords: clinical guidelines; diagnosis; likelihood ratios







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.